Helping biotech companies translate innovative therapeutics into clinical reality
I am Catherine Owczarek, an independent biotechnology consultant with expertise in translational strategy, preclinical planning and clinical readiness.
I work with emerging biotechnology companies developing human therapeutics to define pathways to the clinic, identify key risks and opportunities, and integrate scientific, translational and regulatory considerations to support informed decision-making and successful programme progression.
How I support biotech companies developing human therapeutics
01
Development Planning & Nonclinical Strategy
Defining practical development pathways, identifying evidence gaps and helping translate promising therapeutic science into structured, development-ready programmes.
02
Preclinical Studies & External Partnerships
Working with CROs, academic collaborators and specialist providers to ensure development activities address key scientific questions and generate data that supports informed decisions.
03
Scientific & Translational Support
Integrating scientific, translational and regulatory considerations to support study design, data interpretation and progression toward clinical development.
ABOUT CATHERINE
Bringing translational strategy and development planning together
My experience spans both CSL and emerging biotechnology companies, providing insight into advancing novel human therapeutics from discovery through nonclinical development and towards clinical development.
I have worked across discovery research, translational strategy, preclinical development, development planning and external partner management, helping teams identify key risks and opportunities, define development pathways and make informed decisions.
I work collaboratively with clients to navigate complex scientific and development challenges while maintaining momentum toward clinical development.
01
Translational Strategy
Evaluating scientific opportunities, identifying key development risks and defining practical pathways to advance therapeutic programmes toward clinical development.
Experience and Capabilities
Supporting nonclinical and translational development programmes through scientific strategy, development planning, study oversight and external partnerships.
02
Nonclinical Development Planning
Supporting study planning, prioritisation and evidence-based decision-making to ensure key scientific questions are addressed and programmes progress efficiently toward development milestones.
03
Preclinical Studies & External Partnerships
Supporting the design and review of preclinical studies, and working with CROs, academic collaborators and specialist providers to generate data that informs key development decisions.
Let's discuss what's next
Whether you need support with nonclinical development planning, scientific strategy, study review, external partnerships or development decision-making, I can help bring clarity to complex development challenges.
To get in touch complete the form below or contact me directly using the details provided.
